Commonwealth Financial Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | $947K | Buy |
23,046
+1,827
| +9% | +$75.1K | 1.03% | 8 |
|
2016
Q4 | $843K | Hold |
21,219
| – | – | 0.83% | 16 |
|
2016
Q3 | $890K | Hold |
21,219
| – | – | 0.84% | 18 |
|
2016
Q2 | $785K | Hold |
21,219
| – | – | 0.92% | 15 |
|
2016
Q1 | $812K | Hold |
21,219
| – | – | 1.2% | 7 |
|
2015
Q4 | $1.07M | Buy |
21,219
+11,995
| +130% | +$606K | 3.64% | 7 |
|
2015
Q3 | $422K | Hold |
9,224
| – | – | 0.49% | 20 |
|
2015
Q2 | $538K | Hold |
9,224
| – | – | 0.58% | 13 |
|
2015
Q1 | $509K | Hold |
9,224
| – | – | 0.45% | 16 |
|
2014
Q4 | $463K | Buy |
+9,224
| New | +$463K | 0.41% | 27 |
|